Articles tagged with Virus Testing
Researchers found antibodies that can prevent infection from widely differing strains of HCV in cell culture and animal models. The newly discovered antibodies attach to sites on the viral envelope that seldom mutate, making them promising targets for an HCV vaccine.
A standard food test may fail to detect milk proteins that cause a common childhood allergy, leading to itchy skin and other symptoms. The test's limitations could be improved to better protect consumers with milk allergies.
Researchers developed a disposable microfluidic chip that provides accurate, point-of-care flu diagnosis, replacing expensive lab tests. The chip extracts RNA from Influenza A virus and replicates the sample for detection, producing faster and cheaper results.
Researchers have developed a low-cost, origami-inspired paper sensor that can test for diseases like malaria and HIV. The sensor is easy to produce, assemble, and use, making it suitable for point-of-care testing in resource-constrained areas.
Scientists have developed a method to adapt personal glucose monitors for detecting DNA, allowing for rapid testing of viruses and bacteria in human body fluids and food substances. This technology has the potential to improve health and reduce costs, particularly in developing countries or rural areas with limited medical resources.
A meta-analysis of 159 studies found rapid influenza diagnostic tests (RIDTs) can confirm the flu, but not rule it out; RIDTs are more accurate in children than adults and better at detecting influenza A virus; this suggests routine implementation of RIDTs during flu season could improve patient care.
Two new studies published in Annals of Internal Medicine highlight the importance of rapid diagnosis and treatment of flu. Rapid influenza diagnostic tests (RIDTs) are found to be accurate at diagnosing the flu but not ruling it out, requiring follow-up testing.
Scientists at the University of Leeds create a biosensor technology that can detect Adenovirus viruses, identify individual strains, and count virus particles. This breakthrough could lead to faster, simpler, and less costly testing for viruses, ultimately benefiting patients.
A saliva test used to diagnose HIV has been found to be comparable in accuracy to the traditional blood test, according to a new study. The test showed high sensitivity and specificity rates of 99% and 97%, respectively, making it a promising tool for HIV diagnosis, particularly in high-risk populations.
Research on US healthcare overuse is understudied, but a new study identifies contributing factors and suggests strategies for improvement. The study found that rates of overuse vary widely across services and interventions.
A study found that HPV DNA testing of self-collected Pap specimens was more sensitive than visual inspection with acetic acid and liquid-based cytology, but less specific. This method could expand China's cervical cancer screening outreach without requiring medical professionals or facilities.
Allergy tests are not magic bullets for diagnosis, according to new guidelines from Johns Hopkins Medicine. Blood and skin tests should be used to confirm suspicion and monitor established allergies, but not as standalone diagnostic strategies. This approach aims to prevent misdiagnosis and unnecessary restrictions on patients.
Researchers develop affordable, easy-to-use devices for rapid disease diagnosis in rural communities. Innovative projects include a handheld analyser capable of identifying malaria from DNA fingerprint and a piece of woven fabric that tests blood or urine for disease.
The POBASCAM trial found HPV testing to be more sensitive and effective at detecting precancerous lesions, with fewer high-grade cervical lesions and cervical cancer in the second round of screening. HPV testing can lead to earlier detection and treatment of lesions, improving protection against cervical cancer.
Researchers at the University of Nevada, Reno have licensed a new diagnostic test through IMMY for early detection of cryptococcosis, a fungal meningitis that causes AIDS-related deaths in developing countries. The CrAg Lateral Flow Assay is now available globally, enabling immediate treatment and saving hundreds of thousands of lives.
A new DIY screen for cervical cancer has been shown to be highly effective at detecting the disease in women who cannot access a traditional smear test. The test picked up over four times as many cases of cervical cancer and three times as many pre-cancerous conditions, with higher uptake among women compared to traditional screening.
The NYU College of Nursing is launching a five-year study to test and link care among injecting drug users (IDUs) in Kenya. The project will leverage the country's new needle syringe program to deliver rapid HIV testing, point-of-care CD4 count, and antiretroviral therapy (ART) adherence support.
Recent research highlights that faster diagnostic tests are necessary but not sufficient to improve health outcomes for tuberculosis and HIV patients. The study emphasizes the need for thorough evaluation of diagnostics to ensure technical advancements translate into better patient care.
A French study found that non-targeted HIV rapid test screening in emergency departments identified only a few new cases, often at late stages and among patients in high-risk groups who had been tested previously. The study suggests that targeted HIV screening strategies may be more effective in controlling the epidemic.
A combination of P16 immunohistochemistry and DNA qPCR has been found to accurately determine oropharyngeal squamous cell carcinoma, a form of head and neck cancer derived from HPV16. This test outperforms existing methods with high sensitivity and specificity, making it a valuable tool for clinicians.
Rapid point-of-care CD4 testing has been shown to nearly double the number of patients starting HIV treatment, while reducing dropout rates by half. This improvement is attributed to faster patient staging on-site, allowing for earlier initiation of antiretroviral therapy.
A new study found that persistent HPV infections are associated with a higher risk of cervical cancer. The researchers suggest that re-testing every two years for HPV-positive women can provide useful guidance on the duration of infection and its risk.
A new study suggests that HPV testing for two high-risk strains (HPV16 and HPV18) detects more high-grade pre-cancerous lesions than current cervical cancer screening. The findings support the use of HPV testing as a primary screening tool to rule out disease, with cytology reserved for triage of women who test positive.
A CDC study found that primary care providers continue to recommend annual cervical cancer screening, despite guidelines suggesting a less frequent screening interval. The study suggests that establishing a history of normal Pap tests is crucial in making guideline-supported screening interval recommendations.
Commercial serological tests used to detect active TB do not accurately diagnose the disease, often producing false positives or negatives. In contrast, sputum smear microscopy is found to be more cost-effective and should take priority in tuberculosis control efforts.
A new University of Cincinnati study found that missed opportunities for HIV diagnosis occur in 157 visits to an academic emergency department, 24 visits in an urban community hospital and six visits to a suburban community hospital.
A new automated DNA test for tuberculosis can significantly increase detection rates, especially in HIV-positive patients. However, economic challenges and implications of the diagnostic tests need exploration.
A new TB test, Xpert MTB/RIF, has been shown to be more sensitive and faster than conventional smear microscopy for diagnosing tuberculosis in children. The test detected twice as many cases among children under 15 and identified all confirmed TB cases in children with HIV.
Researchers developed a breath test to measure immune response to H1N1 flu virus. The test detected increased levels of nitric oxide and isoprene in exhaled breath, indicating an immune response triggered on day three after vaccination. This could help prioritize vaccinations for those who need them most.
A new rapid test can accurately diagnose bacterial and viral infections, allowing for timely treatment. The test exploits differences in immune system responses to distinguish between the two types of infections.
A new saliva test has been developed to identify cytomegalovirus (CMV) in newborns with high accuracy, enabling early detection of potential hearing loss. The test, which shows promise in a multi-center study, may revolutionize the way CMV infections are detected and treated in infants.
The American Cancer Society's new report highlights successes and gaps in cancer prevention efforts, including stalled declines in smoking rates and underutilized cancer screening tests. Improving these numbers will require coordinated efforts to address social, economic, and legislative factors influencing individual health behaviors.
A new TB test has been shown to detect tuberculosis and multi-drug resistant TB with high sensitivity and specificity in resource-poor settings. The test can rapidly diagnose those infected, including those with MDR-TB, and reduce delays in diagnosis and treatment.
Researchers at UMMS have developed a novel technique called EMPIRIC to produce all possible individual mutations and analyze their impact on cells. This approach enables the systematic screening of viral genomes for likelihood to develop drug resistance.
Researchers found elevated levels of endothelial microparticles in smokers' blood, even before symptoms appeared. These findings suggest a potential new diagnostic method for early emphysema detection.
A new rapid blood test could lead to early diagnosis and save lives from fungal meningitis, a leading cause of AIDS-related deaths. The test uses a drop of blood or urine sample to identify the presence of cryptococcal antigen.
A recent study found that transmitted drug-resistant (TDR) HIV significantly increases the likelihood of treatment failure, with patients more than three times as likely to experience virological failure. However, pre-treatment genotypic testing and use of ritonavir-boosted protease inhibitors can minimize this risk.
A Stanford study reveals how metaphors influence attitudes towards crime, finding that 'beast' and 'virus' framings lead to different proposed solutions. The researchers found that people are more likely to support increased policing if crime is described as a 'beast', while social reform approaches are favored when crime is seen as a ...
A portable device provides results in under 30 minutes with a small blood sample, revolutionizing point-of-care diagnostics. The device can detect biomarkers of disease and is expected to reduce healthcare costs.
Researchers have developed a method to estimate human age from blood samples, which could be used to identify missing persons or solve crimes. The technique is based on the analysis of T cell receptors and has been shown to be highly accurate, with an error margin of nine years.
Duke University Medical Center will oversee external quality assurance programs for HIV laboratories worldwide, ensuring reliable and reproducible data for treatments, under a $52.8 million NIH contract. The project aims to address global laboratory standards, tracking virus strains and assays for new therapies.
Enterovirus 71, closely related to poliovirus, causes major outbreaks in Asia-Pacific region. Rapid evolution and family transmission facilitate severe cases of neurological disorders like meningitis and paralysis.
A study found that an annual conventional Pap smear is a cost-effective strategy for follow-up after cervical lesion treatment. This approach reduced expected cervical cancer deaths by 73-77% compared to more frequent testing.
A randomized trial found that HPV DNA-based screening and cryotherapy significantly reduced high-grade cervical cancer precursors in unscreened South African women. The study suggests that a 'screen-and-treat' approach can be an effective cervical cancer prevention strategy, especially in low-resource settings.
A new study found that children treated with protease inhibitors and then switched to Nevirapine were more likely to maintain low virus levels. The switch regime is easier for parents to adhere to, saving money, but requires adequate monitoring of virus levels.
A blood test analyzing individual immune responses to infection shows promise for quickly diagnosing respiratory viral illnesses, including flu. The test boasts over 95% accuracy in pinpointing the cause of disease.
A survey of intensive care units in England, Wales and Northern Ireland found that staff often test incapacitated patients without consent after needlestick injuries. The results highlight the need for further discussion on the legality of such tests, as it could be argued that this is unlawful under UK legislation.
Children account for 18% of HIV-related deaths and 15% of infections annually, highlighting the need for improved testing. New approaches, such as routine newborn testing, could help detect more children with HIV in resource-limited settings.
Researchers found that HIV vaccines can induce protective antibody responses, but these responses can also lead to false-positive test results. A study of over 2,000 trial participants revealed that 41.7% developed reactive results in routine antibody detection methods.
A new study conducted jointly by researchers at the University of California, Berkeley, and other institutions found that people who received up to $60 each over 12 months for staying free of sexually transmitted infections (STIs) had a lower prevalence of those infections after a year compared to those who did not receive payments. Th...
A study found that routine HIV screenings in emergency departments resulted in a small increase in newly diagnosed HIV patients, with most diagnoses occurring late in the course of disease. The findings suggest that nontargeted opt-out rapid HIV screening may be an effective prevention strategy.
A novel microfluidic HIV test developed by Prof. Alexander Revzin uses antibodies to 'capture' white blood cells called T cells affected by HIV. The test detects the types and levels of inflammatory proteins released by the cells, providing six parameters simultaneously from a small blood sample.
Alzheimer's disease may not be delayed by lifestyle interventions, while a promising medication, diet, exercise, and cognitive engagement show potential benefits. Ribavirin shows promise in treating Chronic Hepatitis E, and adding nucleic acid testing to HIV screening improves case yield.
Clinical guidelines recommend screening low-risk women every three years after age 30, but most primary care clinicians advocate for more frequent testing. Annual Pap testing has helped decrease cervical cancer burden, but cost-effectiveness models suggest overuse may increase costs with little improvement in outcomes.
Researchers found that adding nucleic acid testing to HIV screening can detect the presence of HIV earlier, increasing detection yield by 23%. A large majority of study participants received negative test results via automated phone or internet systems. The findings suggest that such programs can help control the HIV epidemic.
Research suggests that exposure to herpes simplex virus 1 may contribute to cognitive and brain abnormalities in schizophrenia. Patients with antibodies for HSV-1 performed poorly on cognitive tests and had reduced brain volume in key regions, including the anterior cingulate and cerebellum.
A new technology developed by MIT chemical engineer Christopher Love can analyze individual immune cells taken from patients, allowing for precise measurement of the cells' response to allergens. This approach enables faster and more reliable food allergy diagnoses than current tests.
Researchers developed a dynamic HIV testing device that eliminates human error and requires no technician intervention. The device is 100% accurate, inexpensive, portable, and self-contained, making it suitable for rural clinics and pharmacies in developing countries.
The European Union has approved a new, inexpensive Hepatitis B test that delivers accurate results within half an hour, enabling doctors to take immediate action on health decisions. The test is expected to make a significant impact in helping to curb the spread of disease and has been developed with support from the Wellcome Trust.
A recent study from Stanford University found that DFA testing for H1N1 influenza is unreliable in critically ill patients. The test was more accurate in non-critical cases, with a 26% positive rate in ICU patients compared to an 82% positive rate in non-ICU patients.